Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-<i>b</i>]furan-5,10-diones in Hepatocellular Carcinoma Cells

Engagement with tNOX (ENOX2) to Inhibit SIRT1 and Activate p53-Dependent and -Independent Apoptotic Pathways by Novel 4,11-Diaminoanthra[2,3-<i>b</i>]furan-5,10-diones in Hepatocellular Carcinoma Cells

Hepatocellular carcinoma (HCC) is the most frequent primary malignancy of the liver and is among the top three causes of cancer-associated death worldwide. However, the clinical use of chemotherapy for HCC has been limited by various challenges, emphasizing the urgent need for novel agents with impr...

Full description

Bibliographic Details
Main Authors: Chia-Yang Lin, Atikul Islam, Claire J. Su, Alexander S. Tikhomirov, Andrey E. Shchekotikhin, Show-Mei Chuang, Pin Ju Chueh, Yao Li Chen
Format: Article
Language:English
Published: MDPI AG 2019-03-01
Series:Cancers
Subjects:
apoptosis
anthraquinone derivatives
hepatocellular carcinoma
p53
tumor-associated NADH oxidase (tNOX or ENOX2)
sirtuin 1 (SIRT1)
c-Myc
protein acetylation
Online Access:https://www.mdpi.com/2072-6694/11/3/420

Similar Items

Similar Items